Trial results show PARP inhibitor benefit in 'BRCA-like' breast cancer
by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly extend progression-free surviva
Updated on: January 04,2024
8

Trial results show PARP inhibitor benefit in 'BRCA-like' breast cancer
by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly extend progression-free surviva
Updated on:January 04,2024
8
